ArticleNature communications2026
Biomechanics-informed inertial tracking achieves the accuracy of marker-based kinematics.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Inertial measurement units (IMUs) could transform human movement science by enabling motion tracking outside the laboratory. Yet, their accuracy is perceived as inferior to that of marker-based systems. Here, we introduce IMoveLab, a method that integrates biomechanical priors into state-estimation filters, harnessing coupling across degrees of freedom and the spring-like behavior of muscle-tendon units for recursive state correction. We found that modern state-estimation filters match the accuracy of marker-based knee tracking when evaluated against biplane radiography, the gold standard for skeletal motion. IMoveLab further improves accuracy and achieves drift-free lower-extremity kinematics in long-duration trials, whereas alternative approaches do not. Movement scientists have been anticipating the leap out of the laboratory with cautious optimism. With methods and evidence that support more confident adoption of IMUs, this leap seems less like an aspiration and more like the first line of a new chapter written in the environments where human movement unfolds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.